JOEL E. LOPEZ-MEZA

Dr. JOEL E. LOPEZ-MEZA

Universidad Michoacana de San Nicolás de Hidalgo, Morelia, Michoacán de Ocampo, Mexico
orcid

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2007 in Journal of Infection
Verified
Journal Article
Closed access
JOJavier Oviedo-Boyso
Javier Oviedo-Boyso
JVJuan J. Valdez-Alarcón
Juan J. Valdez-Alarcón
MCMarcos Cajero-Juárez
Marcos Cajero-Juárez
Alejandra Ochoa-ZarzosaAlejandra Ochoa-Zarzosa
Alejandra Ochoa-Zarzosa
JLJOEL E. LOPEZ-MEZA
JOEL E. LOPEZ-MEZA
VBVíctor M. Baizabal-Aguirre
Víctor M. Baizabal-Aguirre

6 June 2012 in Critical Reviews in Microbiology
Verified
Journal Article
Closed access
JLJose Luis Anaya Lopez
Jose Luis Anaya Lopez
JLJOEL E. LOPEZ-MEZA
JOEL E. LOPEZ-MEZA
Alejandra Ochoa-ZarzosaAlejandra Ochoa-Zarzosa
Alejandra Ochoa-Zarzosa
Naturally occurring cationic antimicrobial peptides (CAMPs) have been considered as promising candidates to treat infections caused by pathogenic bacteria to animals and humans. This assumption is based on their mechanism of action, which is mainly performed through electrostatic membrane interactions. Unfortunately, the rise in the reports that describe bacterial resistance to CAMPs has redefined their role as therapeutic agents. In this review, we describe the state of the art of the most common resistance mechanisms developed by bacteria to CAMPs, making special emphasis on resistance selection. Considering most of the resistance mechanisms here reviewed, the emergence of resistance is unlikely in the short term, however we also described evidences that show the evolution of resistance to CAMPs, reevaluating their use as good antibacterial agents. Finally, the knowledge related to the description of CAMP resistance mechanisms may provide useful information for improving strategies to control infections.

1 March 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
JGJaquelina Julia Guzmán-Rodríguez
Jaquelina Julia Guzmán-Rodríguez
Alejandra Ochoa-ZarzosaAlejandra Ochoa-Zarzosa
Alejandra Ochoa-Zarzosa
RLRodolfo López-Gómez
Rodolfo López-Gómez
JLJOEL E. LOPEZ-MEZA
JOEL E. LOPEZ-MEZA
Antimicrobial peptides (AMPs) are part of the innate immune defense mechanism of many organisms and are promising candidates to treat infections caused by pathogenic bacteria to animals and humans. AMPs also display anticancer activities because of their ability to inactivate a wide range of cancer cells. Cancer remains a cause of high morbidity and mortality worldwide. Therefore, the development of methods for its control is desirable. Attractive alternatives include plant AMP thionins, defensins, and cyclotides, which have anticancer activities. Here, we provide an overview of plant AMPs anticancer activities, with an emphasis on their mode of action, their selectivity, and their efficacy.


1 December 2006 in Research in Veterinary Science
Verified
Journal Article
Closed access
JLJose Luis Anaya Lopez
Jose Luis Anaya Lopez
OCOscar E. Contreras-Guzmán
Oscar E. Contreras-Guzmán
ACAlfonso Cárabez-Trejo
Alfonso Cárabez-Trejo
VBVictor M. Baizabal-Aguirre
Victor M. Baizabal-Aguirre
JLJOEL E. LOPEZ-MEZA
JOEL E. LOPEZ-MEZA
Alejandra Ochoa-ZarzosaAlejandra Ochoa-Zarzosa
Alejandra Ochoa-Zarzosa

30 January 2007 in Plant and Soil
Verified
Journal Article
Closed access
PDF file
Eduardo Valencia-CanteroEduardo Valencia-Cantero
Eduardo Valencia-Cantero
EHErasto Hernández-Calderón
Erasto Hernández-Calderón
CVCrisanto Velázquez-Becerra
Crisanto Velázquez-Becerra
JLJOEL E. LOPEZ-MEZA
JOEL E. LOPEZ-MEZA
RARuth Alfaro-Cuevas
Ruth Alfaro-Cuevas
JLJosé López-Bucio
José López-Bucio